BioAtla Inc.

46.00-2.23-4.62%Vol 464.09K1Y Perf 48.65%
Apr 13th, 2021 16:00 DELAYED
BID46.00 ASK46.26
Open48.07 Previous Close48.23
Pre-Market- After-Market-
 - -  - -%
Target Price
69.00 
Analyst Rating
— — 0.00
Potential %
50.00 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★ —    55.77
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap1.55B 
Earnings Rating
Price Range Ratio 52W %
38.10 
Earnings Date
-

Today's Price Range

45.5749.15

52W Range

27.1576.63

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
-5.87%
1 Month
-30.73%
3 Months
-
6 Months
-
1 Year
48.65%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BCAB46.00-2.2300-4.62
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume464.09K
Shares Outstanding33.66M
Trades Count2.30K
Dollar Volume22.18M
Avg. Volume284.31K
Avg. Weekly Volume241.78K
Avg. Monthly Volume349.96K
Avg. Quarterly Volume283.96K

BioAtla Inc. (NASDAQ: BCAB) stock closed at 46 per share at the end of the most recent trading day (a -4.62% change compared to the prior day closing price) with a volume of 464.09K shares and market capitalization of 1.55B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 36 people. BioAtla Inc. CEO is Jay M. Short.

The one-year performance of BioAtla Inc. stock is 48.65%, while year-to-date (YTD) performance is %. BCAB stock has a five-year performance of %. Its 52-week range is between 27.15 and 76.63, which gives BCAB stock a 52-week price range ratio of 38.10%

BioAtla Inc. currently has a PE ratio of -14.90, a price-to-book (PB) ratio of 7.64, a price-to-sale (PS) ratio of 3 550.87, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -28.20%, a ROC of -32.35% and a ROE of -110.89%. The company’s profit margin is -%, its EBITDA margin is -683.50%, and its revenue ttm is $429.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from BioAtla Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. BioAtla Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for BioAtla Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for BioAtla Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioAtla Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioAtla Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 15.79, ATR14 : 2.19, CCI20 : -85.25, Chaikin Money Flow : -0.37, MACD : -1.82, Money Flow Index : 18.03, ROC : -24.25, RSI : 56.42, STOCH (14,3) : 1.95, STOCH RSI : 0.68, UO : 30.47, Williams %R : -98.05), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioAtla Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

CEO: Jay M. Short

Telephone: +1 858 558-0708

Address: 11085 Torreyana Road, San Diego 92121, CA, US

Number of employees: 36

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

33%67%

Bearish Bullish

100%0%

News

Stocktwits